Education
About Us
Working with TipRanks
Follow Us
China Regenerative Medicine International Limited (HK:8158)
:8158
8158 Stock Chart & Stats
HK$0.54
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.54
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.24 - HK$1.20
Previous CloseN/A
Volume500.00
Average Volume (3M)55.39K
Market Cap
HK$164.30M
Enterprise ValueHK$206.61M
Total Cash (Recent Filing)HK$7.28M
Total Debt (Recent Filing)HK$76.05M
Price to Earnings (P/E)29.7
Beta-0.08
Next Earnings
Nov 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.01
Shares Outstanding304,252,470
10 Day Avg. Volume53,325
30 Day Avg. Volume55,386
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)3.56
Price to Sales (P/S)0.99
P/FCF Ratio5.08
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
8158 FAQ
What was China Regenerative Medicine International Limited’s price range in the past 12 months?
China Regenerative Medicine International Limited lowest stock price was HK$0.24 and its highest was HK$1.20 in the past 12 months.
What is China Regenerative Medicine International Limited’s market cap?
China Regenerative Medicine International Limited’s market cap is HK$164.30M.
When is China Regenerative Medicine International Limited’s upcoming earnings report date?
China Regenerative Medicine International Limited’s upcoming earnings report date is Nov 12, 2025 which is 32 days ago.
How were China Regenerative Medicine International Limited’s earnings last quarter?
China Regenerative Medicine International Limited released its earnings results on Aug 22, 2025. The company reported HK$0.015 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.015.
Is China Regenerative Medicine International Limited overvalued?
According to Wall Street analysts China Regenerative Medicine International Limited’s price is currently Overvalued.
Does China Regenerative Medicine International Limited pay dividends?
China Regenerative Medicine International Limited does not currently pay dividends.
What is China Regenerative Medicine International Limited’s EPS estimate?
China Regenerative Medicine International Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Regenerative Medicine International Limited have?
China Regenerative Medicine International Limited has 304,252,470 shares outstanding.
What happened to China Regenerative Medicine International Limited’s price movement after its last earnings report?
China Regenerative Medicine International Limited reported an EPS of HK$0.015 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Regenerative Medicine International Limited?
Currently, no hedge funds are holding shares in HK:8158
China Regenerative Medicine International Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
-12.30%
12-Months-Change
Fundamentals
Return on Equity
20.42%
Trailing 12-Months
Asset Growth
8.84%
Trailing 12-Months
Company Description
China Regenerative Medicine International Limited
China Regenerative Medicine International Limited (8158) is a biotechnology company based in China that specializes in the research, development, and commercialization of regenerative medicine products and technologies. The company primarily focuses on stem cell therapies and tissue engineering, aiming to address various medical conditions and improve patient outcomes. Its core offerings include innovative treatments for orthopedic, cardiovascular, and neurological diseases, leveraging advancements in cellular therapy and biomaterials.
China Regenerative Medicine International Limited (8158) Earnings & Revenues
Technical Analysis
Uni-Bio Science Group Ltd.
―
CANbridge Pharmaceuticals Inc.
―
Clover Biopharmaceuticals Ltd.
―
Sirnaomics Ltd.
―
Transcenta Holding Limited
―